XML 16 R8.htm IDEA: XBRL DOCUMENT v3.22.4
Note 2 - Income Tax Disclosure
12 Months Ended
Sep. 30, 2022
Notes  
Note 2 - Income Tax Disclosure

Note 2 - Income Taxes. At September 30, 2022, the Company had a depletion carryforward of $860,000 and a net operating loss carryforward of $2,247,000, of which $1,949,000 will expire in the years 2028 through 2037. The approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax assets at September 30, 2022, computed in accordance with the Income Tax Topic (Topic 740) of the Codification, is as follows:

 

Deferred Tax Assets

 

2022

 

2021

 Depletion carryforward

$

181,000  

 

181,000  

 Net operating loss carryforward

 

472,000  

 

537,000  

 Accrued shareholder salary

 

215,000  

 

215,000  

 Deletion and amortization

 

3,000  

 

4,000  

Total Net Deferred Tax Assets

 

871,000  

 

937,000  

 Less valuation allowance

 

(871,000) 

 

(937,000) 

Net Deferred Tax Asset

$

 

 

 

 

A valuation allowance has been provided because of the uncertainty of future realization. Income tax expense is different from amounts computed by applying the statutory Federal income tax rate for the following reasons:

 

 

2022

 

2021

Tax expense (benefit) at 21% of net earnings (loss)

$

66,000 

 

(17,000)

Impact of rate change effective January 1, 2018

 

 

Change in valuation allowance for net deferred tax assets

 

(66,000)

 

(17,000)

Income tax expense

$

 

 

As of September 30, 2022, the Company has no unrecognized tax benefit as a result of uncertain tax positions. As of September 30, 2022, the Company’s tax years that remain subject to examination are 2019 - 2022 (Federal jurisdiction) and 2018 - 2022 (state jurisdictions).